Eva Dombi

Also affiliated with Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy

Cancer Cell(2023)10.1016/j.ccell.2023.11.011

N/A

2.4DataRank · unranked

110 citations

Tara Murty, Ahmad Alimadadi, Cristina F. Contreras, Caroline Duault, Priyanka B. Subrahmanyam +39 more

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Neuro-Oncology(2023)10.1093/neuonc/noad086

N/A

2.3DataRank · unranked

97 citations

Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey R. Herrera +14 more

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Nature Medicine(2021)10.1038/s41591-020-01193-6

N/A

2.0DataRank · unranked

96 citations

Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi +25 more

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Neuro-Oncology(2022)10.1093/neuonc/noac109

N/A

1.7DataRank · unranked

66 citations

Brittany Glassberg, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Michael J. Fisher +18 more

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial

Nature Medicine(2025)10.1038/s41591-024-03361-4

N/A

0.954DataRank · unranked

41 citations

Geraldine O’Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G. Herrick, Staci Martin +30 more

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2168

N/A

0.815DataRank · unranked

22 citations

R. Taylor Sundby, Mary Frances Wedekind, Fernanda I. Arnaldez, Jaydira Del Rivero, Lori Wiener +27 more

Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study

The Lancet(2025)10.1016/s0140-6736(25)00986-9

N/A

0.707DataRank · unranked

39 citations

Geraldine O’Sullivan Coyne, Pamela L. Wolters, Staci Martin, Said Farschtschi, Ignacio Blanco +38 more

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709

N/A

0.652DataRank · unranked

20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1

Neuro-Oncology(2024)10.1093/neuonc/noae235

N/A

0.520DataRank · unranked

31 citations

Andrea M. Gross, Carlos G. Romo, Carina Dehner, Alexander J. Lazar, Markku Miettinen +60 more

Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors

American Society of Clinical Oncology Educational Book(2024)10.1200/edbk_432242

N/A

0.505DataRank · unranked

28 citations

Carina Dehner, Eva Dombi, Vanessa Eulo, Andrea M. Gross, R. Taylor Sundby +3 more

Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3612

N/A

0.483DataRank · unranked

24 citations

Andrea M. Gross, Eva Dombi, Cecilia Tibery, Amanda Carbonell, Naoko Takebe +13 more

Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics

medRxiv(2024)10.1101/2024.01.18.24301053

N/A

0.208DataRank · unranked

3 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

Fracture Risk in Pediatric Patients With MEN2B

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac500

N/A

0.170DataRank · unranked

2 citations

Iris R. Hartley, Joanna Kłubo-Gwieździńska, James C. Reynolds, Barbara J. Thomas, J. M. Hogan +9 more

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0797

N/A

0DataRank · unranked

22 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis

Life Science Alliance(2024)10.26508/lsa.202302229

N/A

0DataRank · unranked

5 citations

Niousha Ahmari, Ashley Hall, Mark Jackson, Youjin Na, Jay Pundavela +8 more

Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1696

N/A

0DataRank · unranked

30 citations

John Glod, Melissa Spencer, Miki Kasai, Joanne Derdak, Eva Dombi +9 more

The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa095

N/A

0DataRank · unranked

38 citations

Eva H. Baker, Andrea M. Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak +9 more

Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf201

N/A

0DataRank · unranked

5 citations

Brigitte C. Widemann, Andrea M. Gross, Andrea Baldwin, Said Farschtschi, Victor‐Felix Mautner +2 more

Sacroiliac Joint Involvement: An Underreported Complication of NF1

American Journal of Medical Genetics Part A(2025)10.1002/ajmg.a.64238

N/A

0DataRank · unranked

0 citations

Eva Dombi, Jonathan D. Samet, María Paula Silva Sánchez, Carolyn R. Raski, Michael Sawin +2 more

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561

N/A

0DataRank · unranked

4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more

The prostate is a common site of disease in patients with MEN2B and medullary thyroid carcinoma

Endocrine Related Cancer(2025)10.1530/erc-24-0243

N/A

0DataRank · unranked

0 citations

Srivandana Akshintala, Andrea M. Gross, Eva Dombi, Barış Türkbey, Sandra Bednarova +9 more

Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas

The Laryngoscope(2022)10.1002/lary.30522

N/A

0DataRank · unranked

4 citations

Julie Christensen, Andrea M. Gross, Eva Dombi, Jennifer R Miles, Kelly King +9 more

The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor

Pediatric Blood & Cancer(2023)10.1002/pbc.30358

N/A

0DataRank · unranked

9 citations

Hannah Smith, Maran Ilanchezhian, Robin Lockridge, Karlyne M. Reilly, Margarita Raygada +27 more

Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1

The Journal of Pediatrics(2023)10.1016/j.jpeds.2023.113513

N/A

0DataRank · unranked

6 citations

Eva Dombi, Amish C. Shah, Katherine Smith, Symone M. Brown, Yimei Li +3 more

Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1

Clinical Trials(2023)10.1177/17407745231206402

N/A

0DataRank · unranked

0 citations

Gurbani Singh, Eva Dombi, Pamela L. Wolters, Staci Martin, Andrea Baldwin +14 more